Earth Life Sciences Inc.
CLTS · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $0 | $0 |
| Total Curr. Assets | $1 | $0 | $0 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $4,426 | $176 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $4,426 | $176 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,427 | $176 | $0 | $0 |
| Liabilities | – | – | – | – |
| Payables | $79 | $52 | $57 | $252 |
| Short-Term Debt | $294 | $326 | $281 | $33 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | -$252 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $373 | $378 | $338 | $284 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $294 | $0 | $0 | $0 |
| Other Liabilities | -$294 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $373 | $378 | $338 | $284 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $960 | $465 | $333 | $333 |
| Retained Earnings | -$18,705 | -$17,121 | -$15,293 | -$15,239 |
| AOCI | $132 | $132 | $132 | $132 |
| Other Equity | $21,667 | $16,322 | $14,490 | $14,490 |
| Total Equity | $4,054 | -$202 | -$338 | -$284 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,427 | $176 | $0 | $0 |
| Net Debt | $294 | $326 | $281 | $33 |